Whitney & Co’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.77M | Sell |
18,956
-150
| -0.8% | -$32.3K | 0.35% | 58 |
|
|
2026
Q1 | $4.16M | Buy |
19,106
+537
| +3% | +$119K | 0.35% | 59 |
|
|
2025
Q4 | $4.24M | Buy |
18,569
+11,069
| +148% | +$2.52M | 0.34% | 61 |
|
|
2025
Q3 | $1.74M | Hold |
7,500
| – | – | 0.16% | 68 |
|
|
2025
Q2 | $1.39M | Hold |
7,500
| – | – | 0.14% | 68 |
|
|
2025
Q1 | $1.57M | Hold |
7,500
| – | – | 0.17% | 67 |
|
|
2024
Q4 | $1.33M | Sell |
7,500
-55
| -0.7% | -$10.1K | 0.14% | 65 |
|
|
2024
Q3 | $1.49M | Sell |
7,555
-2
| -0% | -$373 | 0.16% | 62 |
|
|
2024
Q2 | $1.3M | Buy |
7,557
+7
| +0.1% | +$1.16K | 0.15% | 66 |
|
|
2024
Q1 | $1.37M | Buy |
7,550
+50
| +0.7% | +$8.62K | 0.16% | 64 |
|
|
2023
Q4 | $1.16M | Hold |
7,500
| – | – | 0.15% | 64 |
|
|
2023
Q3 | $1.12M | Hold |
7,500
| – | – | 0.17% | 65 |
|
|
2023
Q2 | $1.01M | Sell |
7,500
-50
| -0.7% | -$7.33K | 0.15% | 65 |
|
|
2023
Q1 | $1.2M | Buy |
7,550
+65
| +0.9% | +$9.94K | 0.19% | 62 |
|
|
2022
Q4 | $1.21M | Sell |
7,485
-150
| -2% | -$23K | 0.22% | 62 |
|
|
2022
Q3 | $1.02M | Sell |
7,635
-140
| -2% | -$20.1K | 0.2% | 64 |
|
|
2022
Q2 | $1.19M | Buy |
7,775
+300
| +4% | +$45.8K | 0.22% | 64 |
|
|
2022
Q1 | $1.21M | Sell |
7,475
-75
| -1% | -$10.9K | 0.19% | 67 |
|
|
2021
Q4 | $1.02M | Buy |
7,550
+75
| +1% | +$8.86K | 0.15% | 70 |
|
|
2021
Q3 | $806K | Sell |
7,475
-225
| -3% | -$25.7K | 0.13% | 71 |
|
|
2021
Q2 | $867K | Sell |
7,700
-50
| -0.6% | -$5.63K | 0.14% | 68 |
|
|
2021
Q1 | $839K | Buy |
7,750
+23
| +0.3% | +$2.46K | 0.15% | 67 |
|
|
2020
Q4 | $841K | Sell |
7,727
-596
| -7% | -$57.3K | 0.14% | 73 |
|
|
2020
Q3 | $729K | Buy |
8,323
+6
| +0.1% | +$565 | 0.14% | 73 |
|
|
2020
Q2 | $817K | Buy |
8,317
+221
| +3% | +$19.5K | 0.17% | 64 |
|
|
2020
Q1 | $617K | Sell |
8,096
-43,926
| -84% | -$3.74M | 0.15% | 65 |
|
|
2019
Q4 | $4.61M | Sell |
52,022
-1,175
| -2% | -$97.5K | 0.92% | 50 |
|
|
2019
Q3 | $4.42M | Sell |
53,197
-1,316
| -2% | -$90.2K | 0.92% | 48 |
|
|
2019
Q2 | $3.96M | Sell |
54,513
-665
| -1% | -$52.3K | 0.89% | 46 |
|
|
2019
Q1 | $4.38M | Sell |
55,178
-4,093
| -7% | -$335K | 0.99% | 41 |
|
|
2018
Q4 | $4.66M | Sell |
59,271
-3,195
| -5% | -$281K | 1.19% | 34 |
|
|
2018
Q3 | $5.48M | Sell |
62,466
-45,845
| -42% | -$4.35M | 1.32% | 28 |
|
|
2018
Q2 | $10M | Buy |
108,311
+281
| +0.3% | +$27.4K | 2.68% | 4 |
|
|
2018
Q1 | $10.2M | Sell |
108,030
-2,711
| -2% | -$298K | 2.93% | 3 |
|
|
2017
Q4 | $10.7M | Sell |
110,741
-6,105
| -5% | -$575K | 3.1% | 3 |
|
|
2017
Q3 | $8.47M | Buy |
116,846
+50
| +0% | +$3.81K | 2.84% | 4 |
|
|
2017
Q2 | $8.47M | Buy |
116,796
+1,820
| +2% | +$122K | 2.78% | 4 |
|
|
2017
Q1 | $7.49M | Buy |
114,976
+810
| +0.7% | +$50.9K | 2.72% | 4 |
|
|
2016
Q4 | $7.15M | Buy |
114,166
+965
| +0.9% | +$58.9K | 2.69% | 5 |
|
|
2016
Q3 | $7.14M | Buy |
113,201
+2,514
| +2% | +$163K | 2.86% | 4 |
|
|
2016
Q2 | $6.85M | Buy |
110,687
+756
| +0.7% | +$46.1K | 2.78% | 5 |
|
|
2016
Q1 | $6.28M | Buy |
109,931
+1,780
| +2% | +$99.2K | 2.69% | 5 |
|
|
2015
Q4 | $6.41M | Buy |
108,151
+3,061
| +3% | +$176K | 2.8% | 4 |
|
|
2015
Q3 | $5.72M | Buy |
105,090
+5
| +0% | +$325 | 2.59% | 5 |
|
|
2015
Q2 | $7.06M | Sell |
105,085
-1,040
| -1% | -$67.9K | 3.08% | 3 |
|
|
2015
Q1 | $6.21M | Buy |
106,125
+19,200
| +22% | +$1.16M | 2.78% | 4 |
|
|
2014
Q4 | $5.69M | Sell |
86,925
-1,200
| -1% | -$75.7K | 2.55% | 4 |
|
|
2014
Q3 | $5.09M | Sell |
88,125
-1,925
| -2% | -$107K | 2.35% | 4 |
|
|
2014
Q2 | $5.08M | Buy |
90,050
+2,400
| +3% | +$126K | 2.35% | 5 |
|
|
2014
Q1 | $4.5M | Sell |
87,650
-50
| -0.1% | -$2.53K | 2.27% | 6 |
|
|
2013
Q4 | $4.63M | Buy |
87,700
+9,100
| +12% | +$447K | 2.56% | 3 |
|
|
2013
Q3 | $3.52M | Buy |
78,600
+1,650
| +2% | +$73.1K | 2.46% | 4 |
|
|
2013
Q2 | $3.18M | Buy |
+76,950
| New | +$3.37M | 2.32% | 6 |
|
Other funds holding ABBV
ECSS
ATO
Whitney & Co's ABBV Position: Q2 2026 in Review
Whitney & Co reduced its AbbVie (ABBV) stake by 0.79% in Q2 2026, selling an estimated $32.3K and leaving 18,956 shares worth $4.77M. The position accounts for 0.35% of the portfolio, ranked #58.
Whitney & Co first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $10.7M in Q4 2017. 2,119 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Whitney & Co held 18,956 shares of AbbVie worth $4.77M as of Q2 2026.
- Whitney & Co sold 150 AbbVie shares in Q2 2026, an estimated $32.3K.
- AbbVie made up 0.35% of Whitney & Co's portfolio in Q2 2026, its #58 holding.
- Whitney & Co first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
- Whitney & Co's AbbVie position peaked at $10.7M in Q4 2017.
- 2,119 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Whitney & Co's 13F filing for Q2 2026, filed 28 Jul 2026.